Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. [PDF]
PLoS ONE, 2018 Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation.
Adeline Heraudeau +7 more
doaj +2 more sources
Factor V Leiden thrombophilia [PDF]
Genetics in Medicine, 2011 Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. Deep venous thrombosis and pulmonary embolism are the most common manifestations, but thrombosis in unusual locations also occurs.
J. Kujovich
openaire +3 more sources
Addendum to “on the measurability of a function which occurs in a paper by A. C. Zaanen” [PDF]
Blood, 1963 Current guidelines discourage combined oral contraceptive (COC) use in women with hereditary thrombophilic defects. However, qualifying all hereditary thrombophilic defects as similarly strong risk factors might be questioned. Recent studies indicate the
Buller, Harry R. +6 more
core +14 more sources
Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients [PDF]
Turkish Journal of Hematology, 2011 OBJECTIVE: Budd-Chiari syndrome is a multifactorial disease in which several prothrombotic disorders may predispose patients to the development of thrombosis at this uncommon location (hepatic veins). The aim of this study was to determine the prevalence
Tawhida Y. Abdel Ghaffar +7 more
doaj +4 more sources
BMC Medical Genetics, 2019 Background Preeclampsia can lead to adverse maternal and perinatal outcomes. There are few studies on the association of preeclampsia with thrombophilia in Africa including Sudan.
Nadir A. Ahmed +4 more
doaj +2 more sources
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study [PDF]
Blood, 2000 In a collaborative multicenter case-control study, we investigated the effect of factor V Leiden mutation, prothrombin gene mutation, and inherited deficiencies of protein C, protein S, and antithrombin on the risk of Budd-Chiari ...
Adang, R.P.R. (Rob) +11 more
core +3 more sources
Maternal Factor V Leiden Mutation in Preeclampsia: A Case-Control South Eastern Indian Tertiary Care Hospital Based Study [PDF]
Journal of Clinical and Diagnostic Research, 2020 Introduction: Pre-Eclampsia (PE) is a pregnancy-specific disorder which further complicates and leads to eclampsia. The Factor V Leiden (FVL) is an autosomal dominant genetic abnormality with incomplete penetrance predisposes to thrombosis.
Krishnaveni Changalvala +6 more
doaj +2 more sources
FACTOR V LEIDEN AND THROMBOEMBOLISM [PDF]
Basrah Journal of Surgery, 2004 Zuhair Al-Barazanchi
doaj +2 more sources
Fator V de Leiden Factor V Leiden
Revista Brasileira de Hematologia e Hemoterapia, 2005 José M. P. Godoy
doaj +2 more sources
Radiologic technology, 2020 Factor V Leiden thrombophilia is a genetic mutation that results in hypercoagulation of the blood that presents life-threatening symptoms. This article describes the role of imaging in diagnosis and treatment of cardiovascular complications caused by factor V Leiden and summarizes the etiology, risk factors, symptoms, diagnostic measures, progression ...
Jason S, Applegate, Diane, Gronefeld
openaire +3 more sources